Table 1.
No AKI | AKI (renal replacement) | p-value | |
---|---|---|---|
Baseline |
|
|
|
Male% (n) |
64(40) |
75(6) |
0.79 |
Age ys |
72.6 ± 10.1 |
80 ± 3.7ys |
0.003 |
Weight kg |
83 ± 15 |
87 ± 14 |
0.51 |
Baseline Crea mg/dl |
1.09 ± 0.3 |
1.6 ± 0.84 |
0.13 |
Baseline GFR stage |
2.2 ± 0,6 |
2.25 ± 0,6 |
0.8 |
Elective% (n) |
100(62) |
100(8) |
|
ASA class ≥II% (n) |
34(21) |
62(5) |
0.13 |
Diabetes% (n) |
29(18) |
37(3) |
0.45 |
LV function reduced% (n) |
53(33) |
37(3) |
0.47 |
Surgical data |
|
|
|
Bypass time min |
116 ± 39 |
155 ± 38 |
0.01 |
Cross-clamp time min |
72 ± 32 |
102 ± 36 |
0.02 |
Urine output on bypass ml |
360 ± 290 |
315 ± 310 |
0.32 |
Post-filtration CPB% (n) |
8(5) |
37(3) |
|
CABG% (n) |
62(39) |
25(2) |
0.05 |
Postoperative data |
|
|
|
Fluid balance 24 h ml |
1103 ± 1026 |
1403 ± 860 |
0.001 |
Furosemide total dose 48 h (mg) |
90 ± 60 |
98 ± 65 |
0.4 |
Secondary outcome |
|
|
|
Length ICU stay d |
1,58 ± 1.89 |
23.25 ± 20.88 |
0.000 |
Length hospital stay d |
11 ± 5.9 |
30.6 ± 19.1 |
0.000 |
Mortality 30d% (n) | 6.4(4) | 25(2) | 0.1 |
Significant differences were found in CPB times, length of hospital and ICU stay and age.